Data as of Nov 26
| +0.35 / +2.26%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.50, with a high estimate of 22.00 and a low estimate of 19.00. The median estimate represents a +29.34% increase from the last price of 15.85.
The current consensus among 2 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.